Ok so we have all been on the company's website and had a read of their short, medium and long term goals:
From which I would state the following:
- IRX IP is in a controlled/fixed dose vape, with current market solution unable to provide a true fixed/controlled dose and hence doctors have been reluctant to prescribe
- IRX partner with EC Pharma who provide the C-liquids for the vape & their formulations
When I read the quarterly:
OK so from the above I think its safe to say that the IP for the formulations still belongs to EC Pharma...
From reading the website I had thought that IRXs objective was limited to the controlled dose vape, yet now when I look at the existing drugs to treat CPRS and PD, Cannabis is not listed in either. So really, it seems to me that IRX have become a bio-tech that is using someone else's Cannabis formulation with their delivery device (two sets of IP) to obtain FDA/TGA approval that Cannabis when inhaled can be used to treat these conditions.
I guess now I am wondering:
- Why haven't competitors done this before? Is it because of the favourable cannabis laws in Australia that this hasnt been done in the US?
- If IRX are to become a Biotech why involve EC Pharma and not purchase the required formulations in the first place?
- Is the business model too simple? Would anyone with these conditions not already be able to get their hands on some Marijuana and a vape?
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report
Ok so we have all been on the company's website and had a read...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IRX (ASX) to my watchlist
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.795M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 152584 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 48271 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 152584 | 0.012 |
1 | 83416 | 0.011 |
3 | 550098 | 0.010 |
1 | 100000 | 0.009 |
1 | 120000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 48271 | 1 |
0.020 | 48128 | 2 |
0.033 | 400000 | 1 |
0.039 | 10000 | 1 |
0.040 | 58388 | 1 |
Last trade - 11.04am 15/08/2024 (20 minute delay) ? |
Featured News
IRX (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online